You are here: Industry Insights > Products Guide > Urgent Sourcing Needs of【CPhI.cn】2017.04.24

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Urgent Sourcing Needs of【CPhI.cn】2017.04.24

en-cphi.cnApril 25, 2017

Tag: CPhI , Sourcing Needs , urgent

Favorites

【CPhI.cn】provides the free-of-charge One-to-One Matching Service every week. Your dedicated client service officer collects your sourcing needs and searches suitable suppliers for you to improve your sourcing efficiency greatly.

The validity of the sourcing needs lasts one week.

If your company could provide the following hospital equipment and supplies, you can email the product name to Miki. She will reply you with the detailed information including the buyers' contact information.

Contact Person: Miki

Email: Miki.Zhou@ubmsinoexpo.com

Tel: 86-21-33392254

ID	Name of the Product	CAS No.	Details	Country
1	Triisostearylcitrate	113431-54-2	Quantity:10kgQualityStandards:what'syours?Packing:PlaceofOrigin:ChinaPurity:Standard:DetailedDescription:	China

Previous:INSIGHTEC: First Patient with Benign Brain Tumor has Focused Ultrasound Procedure at Nicklaus Childr

Next:Solidsoft Reply to operate the Irish National Medicine Verification System

What Is PGE (Prostaglandin) And the Effects of Prostaglandins

PharmaSourcesJanuary 02, 2024

Prostaglandins are lipid molecules that act as local chemical messengers in the body. They have a wide range of functions, influencing nearly every physiological system.

Regulatory Compliance in API Drug Production of Different Countries

PharmaSourcesJanuary 02, 2024

A Guide to Prestained Protein Ladders: What, Why, and How

PharmaSourcesNovember 17, 2023

Urgent Sourcing Needs of【CPhI.cn】2017.04.24 | Pharmasources.com

FAQs About Rydapt (Midostaurin): Understanding Its Uses and Benefits

PharmaSourcesNovember 17, 2023

The recent approval of Rydapt (Midostaurin) by the FDA has generated a lot of interest and questions regarding this new targeted therapy for acute myeloid leukemia (AML) and aggressive systemic mastocytosis (ASM).

Urgent Sourcing Needs of【CPhI.cn】2017.04.24

Related News

What Is PGE (Prostaglandin) And the Effects of Prostaglandins

Regulatory Compliance in API Drug Production of Different Countries

A Guide to Prestained Protein Ladders: What, Why, and How

FAQs About Rydapt (Midostaurin): Understanding Its Uses and Benefits

You may like